The Children’s Hospital League Angiogenesis Innovation Fund

The League completed a $500,000 pledge to establish The Children’s Hospital League Angiogenesis Innovation Fund to support the late Dr. Judah Folkman’s visionary cancer research. Angiogenesis inhibitors have received FDA approval in the U.S. for cancer and for the treatment of macular degeneration and are also approved in 27 other countries. Largely because of Folkman’s research, the possibility of antiangiogenic therapy is now on a firm scientific foundation in the treatment of cancer, as well asmany non-neoplastic diseases as well. To date, the League has donated $1,350,000 to cancer research.

Dario Fauza, MD, Tissue Engineering Research

In November 2007, the League pledged to support the research of Dario Fauza, MD, as he pioneers pre -and post-natal treatments for birth defects through fetal tissue engineering. ¬†The League’s support will enable Dr. Fauza to expedite his discoveries from the bench to the bedside, promising healthy lives for countless children who otherwise would not have survived to, or long after, birth.

Peripheral Quantitative Computed Tomography (pQCT)
Scanner for Bone Health

This page is currently being worked on.